Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 41)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A MCK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala MCKESSON CORPORATION (MCK=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
9-Feb-10 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (MCK). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (MCK). 5 $18 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett McKesson Corporation (MCK) Profile & Health Care Industry Trends Analysis 2010 64 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MCK 13 $25 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

Brokerage Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
3-Feb-10 Morgan Keegan & Company, Inc. Jamie Stockton, Jr. HCIT Update 3 $10 View Abstract
27-Jan-10 Morgan Keegan & Company, Inc. Jamie Stockton, Jr. MCK HCIT Results and CCHIT Update 7 $25 View Abstract
12-Jan-10 Thomson StreetEvents N/A MCK - Event Transcript of McKesson Corporation conference call, Jan. 11, 2010 / 3:00pm ET 7 $75 View Abstract
6-Jan-10 Morgan Keegan & Company, Inc. N/A First Look - Jan 06 2010 08:05AM 5 $10 View Abstract
6-Jan-10 Morgan Keegan & Company, Inc. Jamie Stockton, Jr. CERN - Major Deal Announcements 6 $25 View Abstract

Independent Reports (Showing 1 to 10 of 36)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A MCK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala MCKESSON CORPORATION (MCK=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for MEDICAL SUPPLIES 18 $49 View Abstract
9-Feb-10 Stock Traders Daily Thomas H. Kee Jr. Trading Report for (MCK). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (MCK). 5 $18 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett McKesson Corporation (MCK) Profile & Health Care Industry Trends Analysis 2010 64 $149 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MCK 13 $25 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.